1,292
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Evidence for shrunken pore syndrome in children

ORCID Icon, , , , &
Pages 32-38 | Received 15 Aug 2019, Accepted 02 Nov 2019, Published online: 22 Nov 2019

References

  • Bokenkamp A, Herget-Rosenthal S, Bokenkamp R. Cystatin C, kidney function and cardiovascular disease. Pediatr Nephrol. 2006;21:1223–1230.
  • Meng L, Yang Y, Qi LT, et al. Elevated serum cystatin C is an independent predictor of cardiovascular events in people with relatively normal renal function. J Nephrol. 2012;25(3):426–430.
  • Shin MJ, Song SH, Kwak IS, et al. Serum cystatin C as a predictor for cardiovascular events in end-stage renal disease patients at the initiation of dialysis. Clin Exp Nephrol. 2012;16(3):456–463.
  • Foster MC, Inker LA, Levey AS, et al. Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults. Am J Kidney Dis. 2013;62(1):42–51.
  • Grubb A, Lindström V, Jonsson M, et al. Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: ‘Shrunken pore syndrome’. Scand J Clin Lab Invest. 2015;75(4):333–340.
  • Dardashti A, Nozohoor S, Grubb A, et al. Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting. Scand J Clin Lab Invest. 2016;76(1):74–81.
  • Risch M, Risch L, Purde MT, et al. Association of the cystatin C/creatinine ratio with the renally cleared hormones parathyroid hormone (PTH) and brain natriuretic peptide (BNP) in primary care patients: a cross-sectional study. Scand J Clin Lab Invest. 2016;76(5):379–385.
  • Purde MT, Nock S, Risch L, et al. The cystatin C/creatinine ratio, a marker of glomerular filtration quality: associated factors, reference intervals, and prediction of morbidity and mortality in healthy seniors. Transl Res. 2016;169:80–90.
  • Strevens H, Wide-Swensson D, Torffvit O, et al. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest. 2002;62(2):141–147.
  • Kristensen K, Strevens H, Lindström V, et al. Increased plasma levels of beta2-microglobulin, cystatin C and beta-trace protein in term pregnancy are not due to utero-placental production. Scand J Clin Lab Invest. 2008;68(7):649–653.
  • Risch M, Purde MT, Baumann M, et al. High first-trimester maternal blood cystatin C levels despite normal serum creatinine predict pre-eclampsia in singleton pregnancies. Scand J Clin Lab Invest. 2017;77(8):634–643.
  • Jarquin Campos A, Risch L, Baumann M, et al. Shrunken pore syndrome, preeclampsia, and markers of NO metabolism in pregnant women during the first trimester. Scand J Clin Lab Invest. 2019;79(1-2):91–98.
  • Simpson RJ, Hammacher A, Smith DK, et al. Interleukin-6: structure-function relationships. Protein Sci. 1997;6(5):929–955.
  • March CJ, Mosley B, Larsen A, et al. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature. 1985;315(6021):641–647.
  • den Bakker E, Gemke R, van Wijk JAE, et al. Accurate eGFR reporting for children without anthropometric data. Clin Chim Acta. 2017;474:38–43.
  • den Bakker E, Gemke R, Pottel H, et al. Estimation of GFR in children using rescaled beta-trace protein. Clin Chim Acta. 2018;486:259–264.
  • Abbink FC, Laarman CA, Braam KI, et al. Beta-trace protein is not superior to cystatin C for the estimation of GFR in patients receiving corticosteroids. Clin Biochem. 2008;41(4-5):299–305.
  • Fricker M, Wiesli P, Brändle M, et al. Impact of thyroid dysfunction on serum cystatin C. Kidney Int. 2003;63(5):1944–1947.
  • Blufpand HN, Westland R, van Wijk JA, et al. Height-independent estimation of glomerular filtration rate in children: an alternative to the Schwartz equation. J Pediatr. 2013;163(6):1722–1727.
  • Jung K, Klotzek S, Schulze BD. Refinements of assays for low concentrations of inulin in serum. Nephron. 1990;54(4):360–361.
  • Degenaar CP, Frenken LAM, von Hooff JP. Enzymatic method for the determination of inulin. Clin Chem. 1987;33(6):1070–1071.
  • Grubb A, Blirup-Jensen S, Lindström V, et al. First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med. 2010;48(11):1619–1621.
  • den Bakker E, Gemke R, van Wijk JAE, et al. Combining GFR estimates from cystatin C and creatinine-what is the optimal mix? Pediatr Nephrol. 2018;33(9):1553–1563.
  • Pottel H, Hoste L, Dubourg L, et al. An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant. 2016;31(5):798–806.
  • Pottel H, Delanaye P, Schaeffner E, et al. Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant. 2017;32(3):497–507.
  • Juraschek SP, Coresh J, Inker LA, et al. Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population. Clin J Am Soc Nephrol. 2013;8(4):584–592.
  • den Bakker E, Gemke R, Bökenkamp A. Endogenous markers for kidney function in children: a review. Crit Rev Clin Lab Sci. 2018;55(3):163–183.
  • Tin A, Astor BC, Boerwinkle E, et al. Genome-wide significant locus of beta-trace protein, a novel kidney function biomarker, identified in European and African Americans. Nephrol Dial Transplant. 2013;28(6):1497–1504.
  • Loew M, Hoffmann MM, Koenig W, et al. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events. Arterioscler Thromb Vasc Biol. 2005;25(7):1470–1474.
  • Groesbeck D, Köttgen A, Parekh R, et al. Age, gender, and race effects on cystatin C levels in US adolescents. Clin J Am Soc Nephrol. 2008;3(6):1777–1785.
  • Ziegelasch N, Vogel M, Müller E, et al. Cystatin C serum levels in healthy children are related to age, gender, and pubertal stage. Pediatr Nephrol. 2019;34(3):449–457.
  • Lindström V, Grubb A, Alquist Hegbrant M, et al. Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration. Scand J Clin Lab Invest. 2008;68(8):685–691.
  • White CA, Ghazan-Shahi S, Adams MA. β-Trace protein: a marker of GFR and other biological pathways. Am J Kidney Dis. 2015;65(1):131–146.
  • Tenstad O, Roald AB, Grubb A, et al. Renal handling of radiolabelled human cystatin C in the rat. Scand J Clin Lab Invest. 1996;56(5):409–414.
  • Deen WM, Lazzara MJ, Myers BD. Structural determinants of glomerular permeability. Am J Physiol Renal Physiol. 2001;281(4):F579–F596.
  • Kristensen K, Wide-Swensson D, Schmidt C, et al. Cystatin C, beta-2-microglobulin and beta-trace protein in pre-eclampsia. Acta Obstet Gynecol Scand. 2007;86(8):921–926.
  • Rippe C, Asgeirsson D, Venturoli D, et al. Effects of glomerular filtration rate on Ficoll sieving coefficients (theta) in rats. Kidney Int. 2006;69(8):1326–1332.
  • Lund U, Rippe A, Venturoli D, et al. Glomerular filtration rate dependence of sieving of albumin and some neutral proteins in rat kidneys. Am J Physiol Renal Physiol. 2003;284(6):F1226–F1234.
  • Perrin N, Berg UB. Estimated glomerular filtration rates cannot replace measured GFR in type 1 diabetes patients with hyperfiltration. Acta Paediatr. 2015;104(7):730–737.
  • Huang SH, Sharma AP, Yasin A, et al. Hyperfiltration affects accuracy of creatinine eGFR measurement. Clin J Am Soc Nephrol. 2011;6(2):274–280.
  • Leion F, Hegbrant J, den Bakker E, et al. Estimating glomerular filtration rate (GFR) in children. The average between a cystatin C- and a creatinine-based equation improves estimation of GFR in both children and adults and enables diagnosing Shrunken Pore Syndrome. Scand J Clin Lab Invest. 2017;77(5):338–344.
  • Almén MS, Björk J, Nyman U, et al. Shrunken Pore Syndrome is associated with increased levels of atherosclerosis-promoting proteins. Kidney Int Rep. 2019;4(1):67–79.
  • Christensson A, Grubb A, Molvin J, et al. The shrunken pore syndrome is associated with declined right ventricular systolic function in a heart failure population – the HARVEST study. Scand J Clin Lab Invest. 2016;76(7):568–574.
  • Purde MT, Nock S, Risch L, et al. Ratio of cystatin C and creatinine-based estimates of the glomerular filtration rate predicts mortality in healthy seniors independent of kidney function. Scand J Clin Lab Invest. 2016;76(4):341–343.
  • Cheung CL, Lam KS, Cheung BM. Serum beta-2 microglobulin concentration predicts cardiovascular and all-cause mortality. Int J Cardiol. 2013;168(5):4811–4813.
  • Shafi T, Parekh RS, Jaar BG, et al. Serum β-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2012;7(9):1435–1445.
  • Tangri N, Inker LA, Tighiouart H, et al. Filtration markers may have prognostic value independent of glomerular filtration rate. J Am Soc Nephrol. 2012;23(2):351–359.
  • Bhavsar NA, Appel LJ, Kusek JW, et al. Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis. 2011;58(6):886–893.
  • Sundin PO, Sjöström P, Jones I, et al. Measured glomerular filtration rate does not improve prediction of mortality by cystatin C and creatinine. Nephrol Dial Transplant. 2017;32(4):663–670.